Leveraging the potential for deintensification in cancer care

IF 23.5 1区医学 Q1 ONCOLOGY

Nature cancer Pub Date : 2024-09-20 DOI:10.1038/s43018-024-00827-9

Jennifer A. Soon, Fanny Franchini, Maarten J. IJzerman, Grant A. McArthur

引用次数: 0

Abstract

Evidence-based reductions in cancer treatment that still preserve outcomes can result in an improved quality of life for patients and optimized healthcare resourcing. Using melanoma as an example, we define treatment deintensification, outlining barriers to its implementation, as well as existing guidance.

查看原文本刊更多论文

在癌症治疗中发挥去强化化的潜力。

以证据为基础减少癌症治疗，但仍能保持疗效，可提高患者的生活质量，优化医疗资源。以黑色素瘤为例，我们将定义去强化治疗，概述其实施障碍以及现有指南。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature cancer Medicine-Oncology

CiteScore

31.10

自引率

1.80%

发文量

129

期刊介绍： Cancer is a devastating disease responsible for millions of deaths worldwide. However, many of these deaths could be prevented with improved prevention and treatment strategies. To achieve this, it is crucial to focus on accurate diagnosis, effective treatment methods, and understanding the socioeconomic factors that influence cancer rates. Nature Cancer aims to serve as a unique platform for sharing the latest advancements in cancer research across various scientific fields, encompassing life sciences, physical sciences, applied sciences, and social sciences. The journal is particularly interested in fundamental research that enhances our understanding of tumor development and progression, as well as research that translates this knowledge into clinical applications through innovative diagnostic and therapeutic approaches. Additionally, Nature Cancer welcomes clinical studies that inform cancer diagnosis, treatment, and prevention, along with contributions exploring the societal impact of cancer on a global scale. In addition to publishing original research, Nature Cancer will feature Comments, Reviews, News & Views, Features, and Correspondence that hold significant value for the diverse field of cancer research.